Extracellular Histones-Friend or Foe?
- PMID: 35925543
- DOI: 10.1007/s12098-022-04335-5
Extracellular Histones-Friend or Foe?
Comment on
-
Circulating Histones and Severity of Illness in Children with Sepsis: A Prospective Observational Study.Indian J Pediatr. 2022 Oct;89(10):989-995. doi: 10.1007/s12098-022-04084-5. Epub 2022 Feb 18. Indian J Pediatr. 2022. PMID: 35181838
References
-
- Li Y, Wan D, Luo X, et al. Circulating histones in sepsis: potential outcome predictors and therapeutic targets. Front Immunol. 2021;12:650184. - DOI
-
- Karki P, Birukov KG, Birukova AA. Extracellular histones in lung dysfunction: a new biomarker and therapeutic target? Pulm Circ. 2020;10:2045894020965357. - DOI
-
- Cheng Z, Abrams ST, Alhamdi Y, et al. Circulating histones are major mediators of multiple organ dysfunction syndrome in acute critical illnesses. Crit Care Med. 2019;47:e677–84. - DOI
-
- Sidana V, Ismail J, Nallasamy K, Bhatia P, Jayashree M. Circulating histones and severity of illness in children with sepsis: a prospective observational study. Indian J Pediatr. 2022. https://doi.org/10.1007/s12098-022-04084-5 . - DOI - PubMed - PMC
-
- Abrams ST, Su D, Sahraoui Y, et al. Assembly of alternative prothrombinase by extracellular histones initiates and disseminates intravascular coagulation. Blood. 2021;137:103–14. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
